Pharmacological validation of TDO as a target for Parkinson’s disease-Reference-Cited by-同舟云学术

Pharmacological validation of TDO as a target for Parkinson’s disease

Published:2021-02-18 Issue:14 Volume:288 Page:4311-4331
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Perez‐Pardo Paula¹^ORCID,Grobben Yvonne²,Willemsen‐Seegers Nicole²,Hartog Mitch¹,Tutone Michaela¹,Muller Michelle²,Adolfs Youri³,Pasterkamp Ronald Jeroen³,Vu‐Pham Diep²,Doornmalen Antoon M.²,Cauter Freek²,Wit Joeri²,Gerard Sterrenburg Jan²,Uitdehaag Joost C.M.²,Man Jos²,Buijsman Rogier C.²,Zaman Guido J.R.²^ORCID,Kraneveld Aletta D.¹

Affiliation:

1. Division of Pharmacology Faculty of Science Utrecht Institute for Pharmaceutical SciencesUtrecht University Utrecht The Netherlands

2. Netherlands Translational Research Center B.V Oss The Netherlands

3. Department of Translational Neuroscience UMC Utrecht Brain CenterUniversity Medical Center UtrechtUtrecht University Utrecht The Netherlands

Funder

Michael J. Fox Foundation for Parkinson's Research

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.15721